Capsular Localization of theCryptococcus neoformansPolysaccharide Component Galactoxylomannan
Open Access
- 1 January 2009
- journal article
- research article
- Published by American Society for Microbiology in Eukaryotic Cell
- Vol. 8 (1) , 96-103
- https://doi.org/10.1128/ec.00331-08
Abstract
Cryptococcus neoformans capsular polysaccharide is composed of at least two components, glucuronoxylomannan (GXM) and galactoxylomannans (GalXM). Although GXM has been extensively studied, little is known about the location of GalXM in the C. neoformans capsule, in part because there are no serological reagents specific to this antigen. To circumvent the poor immunogenicity of GalXM, this antigen was conjugated to protective antigen from Bacillus anthracis as a protein carrier. The resulting conjugate elicited antibodies that reacted with GalXM in mice and yielded an immune serum that proved useful for studying GalXM in the polysaccharide capsule. In acapsular cells, immune serum localized GalXM to the cell wall. In capsulated cells, immune serum localized GalXM to discrete pockets near the capsule edge. GalXM was abundant on the nascent capsules of budding daughter cells. The constituent sugars of GalXM were found in vesicle fractions consistent with vesicular transport for this polysaccharide. In addition, we generated a single-chain fraction variable fragment antibody with specificity to oxidized carbohydrates that also produced punctate immunofluorescence on encapsulated cells that partially colocalized with GalXM. The results are interpreted to mean that GalXM is a transient component of the polysaccharide capsule of mature cells during the process of secretion. Hence, the function of GalXM appears to be more consistent with that of an exopolysaccharide than a structural component of the cryptococcal capsule.This publication has 43 references indexed in Scilit:
- Binding of the Wheat Germ Lectin to Cryptococcus neoformans Suggests an Association of Chitinlike Structures with Yeast Budding and Capsular GlucuronoxylomannanEukaryotic Cell, 2008
- Spleen deposition ofCryptococcus neoformanscapsular glucuronoxylomannan in rodents occurs in red pulp macrophages and not marginal zone macrophages expressing the C-type lectin SIGN-R1Medical Mycology, 2008
- Galactoxylomannan Does Not Exhibit Cross-Reactivity in the PlateliaAspergillusEnzyme ImmunoassayClinical and Vaccine Immunology, 2007
- Vesicular Polysaccharide Export in Cryptococcus neoformans Is a Eukaryotic Solution to the Problem of Fungal Trans-Cell Wall TransportEukaryotic Cell, 2007
- Radial Mass Density, Charge, and Epitope Distribution in theCryptococcus neoformansCapsuleEukaryotic Cell, 2007
- The molecular basis for the immunogenicity ofCryptococcus neoformansmannoproteinsFEMS Yeast Research, 2006
- Radiological Studies Reveal Radial Differences in the Architecture of the Polysaccharide Capsule ofCryptococcus neoformansEukaryotic Cell, 2005
- UGD1 , Encoding the Cryptococcus neoformans UDP-Glucose Dehydrogenase, Is Essential for Growth at 37°C and for Capsule BiosynthesisEukaryotic Cell, 2004
- Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization.The Journal of Experimental Medicine, 1993
- An anti-Cryptococcus neoformans monoclonal antibody directed against galactoxylomannanResearch in Immunology, 1990